Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on June 2, 2026

8 hours ago

TG Therapeutics to Participate in the Goldman Sachs 47th Annual Healthcare Conference

Indeterminate GlobeNewswire

8 hours ago

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia

Indeterminate GlobeNewswire

8 hours ago

QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston

Indeterminate GlobeNewswire

8 hours ago

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Indeterminate GlobeNewswire

9 hours ago

CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth

Indeterminate GlobeNewswire

9 hours ago

Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer

Indeterminate GlobeNewswire

9 hours ago

Ocugen to Participate in Upcoming June Investor and Industry Conferences

Indeterminate GlobeNewswire

9 hours ago

Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

9 hours ago

Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions

Indeterminate GlobeNewswire

9 hours ago

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

Indeterminate GlobeNewswire

9 hours ago

Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts

Indeterminate GlobeNewswire

9 hours ago

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study

Indeterminate GlobeNewswire

9 hours ago

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

Indeterminate GlobeNewswire

9 hours ago

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Indeterminate GlobeNewswire

9 hours ago

SEED Therapeutics Highlights Clinical Advancement and Broad Oncology Potential of ST-01156, an RBM39 Molecular Glue Degrader in First-in-Human in Phase 1 Studies, at ASCO 2026

Indeterminate GlobeNewswire

9 hours ago

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy

Indeterminate GlobeNewswire

9 hours ago

Telix and United Imaging Announce Strategic Theranostics Collaboration

Indeterminate GlobeNewswire

9 hours ago

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Indeterminate GlobeNewswire

9 hours ago

Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region

Indeterminate GlobeNewswire

9 hours ago

Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Indeterminate GlobeNewswire